LINC02143: A Potential Drug Target and Biomarker (G101927835)

Target Name: LINC02143

NCBI ID: G101927835

LINC02143

Other Name(s): Long intergenic non-protein coding RNA 2143 | long intergenic non-protein coding RNA 2143

LINC02143: A Potential Drug Target and Biomarker

Long intergenic non-protein coding RNAs (lncNPs) have emerged as a promising source of new biomarkers and drug targets in recent years. These non-coding RNAs play a crucial role in gene regulation and can be expressed in different cell types and states. One of the most well-studied lncNPs is LINC02143, which has been identified as a potential drug target and biomarker.

LINC02143 is a transcribed RNA molecule that is located between the intron and the 5' end of a gene. It is characterized by its ability to act as a scaffold to recruit chromatin-remodeling complexes to specific genomic regions, which can lead to changes in gene expression and cellular behavior. LINC02143 has been shown to play a role in regulating gene expression and can be used to study the effects of drugs on gene function.

Despite its potential as a drug target, LINC02143 is not yet a proven drug target. However, several studies have suggested that LINC02143 may be a promising drug target for the treatment of various diseases. For example, LINC02143 has been shown to be highly expressed in cancer tissues and has been associated with cancer progression. Additionally, LINC02143 has been shown to play a role in the regulation of cell adhesion, which is a critical process for the maintenance of tissue structure and function.

In addition to its potential as a drug target, LINC02143 may also be used as a biomarker for various diseases. For example, LINC02143 has been shown to be highly expressed in heart failure samples and has been associated with poor prognosis in these patients. Additionally, LINC02143 has been shown to be regulated by factors such as age, gender, and environmental factors, which could make it a useful biomarker for studying the effects of drugs on these factors.

In conclusion, LINC02143 is a promising RNA molecule that has the potential to be a drug target and biomarker. Further research is needed to fully understand its functions and to determine its potential as a therapeutic agent. By studying the effects of drugs on LINC02143, researchers may be able to develop new treatments for a variety of diseases.

Protein Name: Long Intergenic Non-protein Coding RNA 2143

The "LINC02143 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02143 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets